-
Most Popular
![Growth Stocks Icon](https://investorplace.com/wp-content/uploads/2022/11/growth_stocks-150x150.png)
Growth Stocks
Looking for 10x, 20x, even 50x gains? Growth stocks are the perfect place to start. These are shares of innovative companies that outpace the market, and they’ve created billionaires virtually overnight. Don’t expect dividends, slow-and-steady growth or cheap price tags (you can head on over to read about undervalued stocks if that’s what you’re looking for). Instead, you’ll pay a premium price for the potential of multi-bagger gains. Read on to learn how you can profit from investing in growth stocks.
![a green button on a keyboard has an arrow pointing upward with the word "Buy". bill ackman stocks. stocks to buy. most undervalued stocks with strong fundamentals to buy in April. Stocks to Buy](https://investorplace.com/wp-content/uploads/2020/04/stockstobuy1600_11-150x150.jpg)
The 3 Best Stocks to Buy Right Now With $1,000
The best stocks to buy if you have $1,000 to put to work today will be those that help your portfolio grow no matter what the market does.
![Human hand touching the thumb of a 3D printed hand](https://investorplace.com/wp-content/uploads/2021/02/3d-printing-hand-1600-150x150.jpg)
The 3 Best 4D Printing Stocks to Buy Now
Investors might want to consider keeping an eye on the best 4D printing stocks on the market as the industry begins to become relevant.
![A concept image showing a quantum computer with a matrix background; quantum computing. leading quantum stocks, Best Quantum Computing Stocks to Buy](https://investorplace.com/wp-content/uploads/2022/09/quantum-computing-3-150x150.jpg)
3 Quantum Computing Stocks to Bet on for Market-Crushing Returns
Quantum computing holds massive potential, creating substantial opportunity for quantum computing stocks.
Recent Growth Stocks Articles
Rivian (RIVN) Stock Falls as Hybrid EV Sales Ramp Up
RIVN stock is sinking lower amid strong hybrid sales and Ford reducing the prices of its electric pickup truck.
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
Vertex hopes Alpine's drug can be tested on other conditions beyond the one entering Phase 3 trial for a kidney disease.